How does the urothelium affect bladder function in health and disease?: ICI-RS 2011

Neurourology and Urodynamics

Volumn 31, Issue 3, 2012, Pages 293-299

  Birder, L A ^a   Ruggieri, M ^b   Takeda, M ^c   Van Koeveringe, G ^d   Veltkamp, S ^e   Korstanje, C ^e   Parsons, B ^f   Fry, C H ^g  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Astellas Pharma Global Development   (Netherlands)

^f SOUTHMEAD HOSPITAL   (United Kingdom)

^g UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

barrier; epithelium; sensor; treatment

Indexed keywords

ADENOSINE TRIPHOSPHATE; CAPSAICIN; CHITOSAN; CYCLIC GMP; CYCLOPHOSPHAMIDE; METHOTREXATE; MUSCARINIC RECEPTOR; NITRIC OXIDE; OXYBUTYNIN; PROSTAGLANDIN E2; PROTAMINE SULFATE; RESINIFERATOXIN; TACHYKININ; VANILLOID RECEPTOR;

BACTERIAL INFECTION; BLADDER CONTRACTION; BLADDER DISEASE; BLADDER FUNCTION; BLADDER MUCOSA; CELL STRUCTURE; CELLULAR STRESS RESPONSE; DRUG DELIVERY SYSTEM; HUMAN; INTERSTITIAL CYSTITIS; MECHANICAL STRESS; NONHUMAN; OVERACTIVE BLADDER; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; UNDERACTIVE BLADDER; URINARY TRACT INFECTION; UROTHELIUM;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL MARKERS; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MUSCLE CONTRACTION; MUSCLE RELAXATION; RECEPTORS, MUSCARINIC; TRPV CATION CHANNELS; URINARY BLADDER; URINARY BLADDER DISEASES; URODYNAMICS; UROTHELIUM;

EID: 84859100133     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.22195     Document Type: Review

References (110)

1. Khanderlwal P, Apodaca G,. Cell biology and physiology of the uroepithelium. Am J Physiol 2009; 297: F1477-501.
2. Birder LA, de Groat WC,. Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pract Urol 2007; 4: 46-54.
3. Robinson D, Cardozo L,. Estrogens and the lower urinary tract. Neurourol Urodyn 2011; 30: 754-7.
4. Erikson BC, Hunskar S,. Urogenital estrogen deficiency syndrome; Investigation and treatment with special reference to hormone substitution. Tidsskr Nor Laegeforen 1991; 111: 2249-51.
5. Dautzenber FM, Hauger RL,. The CRF peptide family and their receptors: Yet more partners discovered. Trends Pharma Sci 2002; 23: 71-7.
6. Rostand KS, Esko J,. Microbial adherence to and invasion through proteoglycans. Infect Immun 1997; 65: 1-8.
7. Bishop BL, Duncan MJ, Song J, et al. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 2007; 13: 625-30.
8. Resnick NM, Yalla S,. Aging and its effect on the bladder. Sem Urol 1987; 2: 82-6.
9. Canon E, Timmermans LG, Reznik M, et al. Ultrastructural modifications of the bladder wall in senescence. Acta Urol Belg 1990; 58: 29-40.
10. Al-Motabagani MA,. Age-related changes in the urinary bladder of the female albino rats. Int J Morphol 2005; 23: 309-16.
11. Christiaansen CE, Sun Y, Hsu YC, et al. Alterations in expression of HIF-1α, HIF-2α, and VEGF by idiopathic overactive bladder urothelial cells during stretch suggest role for hypoxia. Urology 2011; 77: 1266.e7-11.
12. Liu G, Daneshgari F,. Temporal diabetes- and diuresis-induced remodeling of the urinary bladder in the rat. Am J Physiol 2006; 291: R837-43.
13. Changolkar AK, Hypolite JA, Disanto M, et al. Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol 2005; 173: 309-13.
14. Beshay E, Carrier S,. Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model. Urology 2004; 64: 1062-7.
15. Chopra B, Barrick S, Meyers S, et al. Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol 2005; 562: 859-71.
16. Murray E, Malley S, Qiao LY, et al. Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic ganglia and bladder. J Urol 2004; 172: 2434-9.
17. Birder LA, Ruan H, Chopra B, et al. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol 2004; 287: F1084-91.
18. Lee HY, Bardini M, Burnstock G,. Distribution of P2X receptors in the urinary bladder and the ureter of the rat. J Urol 2000; 163: 2002-7.
19. Tempest HV, Dixon A, Turner WH, et al. P2X receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 2004; 93: 1344-8.
20. Birder LA, Apodaca G, de Groat WC, et al. Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol 1998; 275: F226-9.
21. Birder LA, Nealen M, Kiss S, et al. Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci 2002; 22: 8063-70.
22. Beckel JM, Kanai A, Lee SJ, et al. Expression of functional nicotinic acetylcholine receptors in rat urinary bladder epithelial cells. Am J Physiol 2006; 290: F103-10.
23. Chess-Williams R,. Muscarinic receptors of the urinary bladder: Detrusor, urothelial and prejunctional. Auton Autacoid Pharmacol 2002; 22: 133-45.
24. D'Andrea MR, Saban M, Nguyen NB, et al. Expression of protease-activated receptor-1, -2, -3, and -4 in control and experimentally inflamed mouse bladder. Am J Pathol 2003; 162: 907-23.
25. Carattino MD, Sheng S, Kleyman TR,. Mutations in the pore region modify epithelial sodium channel gating by shear stress. J Biol Chem 2005; 280: 4393-401.
26. Lewis SA, Hanrahan J,. Apical and basolateral membrane ionic channels in rabbit urinary bladder epithelium. Pflugers Arch 1985; 405: S83-8.
27. Smith PR, Mackler S, Weiser PC, et al. Expression and localization of epithelial sodium channel in mammalian urinary bladder. Am J Physiol 1998; 274: F91-6.
28. Wang EC, Lee J, Johnson JP, et al. Hydrostatic pressure-regulated ion transport in bladder uroepithelium. Am J Physiol 2003; 285: F651-63.
29. Araki I, Du S, Kamiyama M, et al. Overexpression of epithelial sodium channels in epithelium of human urinary bladder with outlet obstruction. Urology 2004; 64: 1255-60.
30. Du S, Araki I, Mikami Y, et al. Amiloride-sensitive ion channels in urinary bladder epithelium involved in mechanosensory transduction by modulating stretch-evoked adenosine triphosphate release. Urology 2007; 69: 590-5.
31. Yoshimura N, Kaiho Y, Miyazato M, et al. Therapeutic receptor targets for lower urinary tract dysfunction. Naunyn Schm Arch Pharmacol 2008; 377: 437-48.
32. Birder LA, Kanai A, de Groat WC, et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 2001; 98: 13396-401.
33. Birder LA, Nakamura Y, Kiss S, et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 2002; 5: 856-60.
34. Birder LA, Kullmann F, Lee H, et al. Activation of urothelial transient receptor potential vanilloid 4 by 4-alpha-phorbol 12,13-didecanote contributes to altered bladder reflexes in the rat. J Pharmacol Exp Ther 2007; 323: 227-335.
35. Stein RJ, Nagatomi J, Hayashi Y, et al. Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol 2004; 172: 1175-8.
36. Streng T, Axelsson HE, Hedlund P, et al. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 2008; 53: 391-9.
37. Downie JW, Karmazny M,. Mechanical trauma to bladder epithelium liberates prostanoids which modulate neurotransmission in rabbit detrusor muscle. J Pharmacol Exp Ther 1984; 230: 445-9.
38. Ferguson DR, Kennedy I, Burton TJ,. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-A possible sensory mechanism ? J Physiol 1997; 505: 503-11.
39. Wang EC, Lee J, Ruiz WG, et al. ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest 2005; 115: 2412-22.
40. Yoshida M, Inadome A, Maeda Y, et al. Non-neuronal cholinergic system in human bladder urothelium. Urology 2006; 67: 425-30.
41. Andersson KE,. Bladder activation: Afferent mechanisms. Urology 2002; 59: 43-50.
42. Sabirov RZ, Okada Y,. ATP-conducting maxi-anion channel: A new player in stress-sensory transduction. Jpn J Physiol 2004; 54: 7-14.
43. Burnstock G,. Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 2001; 22: 182-8.
44. Rong W, Spyer K, Burnstock G,. Activation and sensitization of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J Physiol 2002; 541: 591-600.
45. Ishihama H, Momota Y, Yanase H, et al. Activation of alpha 1D adrenergic receptors in the rat urothelium facilitates the micturition reflex. J Urol 2006; 175: 358-64.
46. Birder LA, Barrick S, Roppolo JR, et al. Feline interstitial cystitis results in mechanical hyper-sensitivity and altered ATP release from bladder urothelium. Am J Physiol 2003; 285: F423-9.
47. Voets T, Talavera K, Owsianik G, et al. Sensing with TRP channels. Nat Chem Biol 2005; 1: 85-92.
48. Moran MM, Xu H, Clapham DE,. TRP ion channels in the nervous system. Curr Opin Neurobiol 2004; 14: 362-9.
49. Suzuki M, Mizuno A, Kodaira K, et al. Impaired pressure sensation in mice lacking TRPV4. J Biol Chem 2003; 278: 22664-8.
50. Liedtke W, Friedman J,. Abnormal osmotic regulation in TRPV4-/- mice. Proc Natl Acad Sci USA 2003; 100: 13698-703.
51. Avelino A, Cruz F,. TRPV1 (vanilloid receptor) in the urinary tract: Expression, function and clinical applications. Naunyn Schmd Arch Pharmacol 2006; 373: 287-99.
52. Gevaert T, Vriens J, Segal A, et al. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 2007; 117: 3453-62.
53. 2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem 2009; 284: 21257-64.
54. Du S, Araki I, Kobayashi H, et al. Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs. Urology 2008; 72: 450-5.
55. Andersson KE, Gratzke C, Hedlund P,. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder. BJU Int 2010; 106: 1114-27.
56. Skryma R, Prevarskaya N, Gkika D, et al. From urgency to frequency: Facts and controversies of TRPs in the lower urinary tract. Nat Rev Urol 2011 8: 617-30.
57. Mukerji G, Yiangou Y, Corcoran SL,. Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations. BMC Urol 2006; 6: 6.
58. Andrade EL, Forner S, Bento AF, et al. TRPA1 receptor modulation attenuates bladder overactivity induced by spinal cord injury. Am J Physiol Renal Physiol 2011; 300: F1223-34.
59. Sui GP, Wu C, Roosen A, et al. Modulation of bladder myofibroblast activity: Implications for bladder function. Am J Physiol 2008; 295: F688-97.
60. Akino H, Chapple CR, McKay N, et al. Spontaneous contractions of the pig urinary bladder: The effect of ATP-sensitive potassium channels and the role of the mucosa. BJU Int 2008; 102: 1168-74.
61. Ikeda Y, Kanai A,. Urotheliogenic modulation of intrinsic activity in spinal cord-transected rat bladders: Role of mucosal muscarinic receptors. Am J Physiol 2008; 295: F454-61.
62. Sadananda P, Chess-Williams R, Burcher E,. Contractile properties of the pig bladder mucosa in response to neurokinin A: A role for myofibroblasts ? Br J Pharmacol 2008; 153: 1465-73.
63. Thompson SA, Copeland CR, Reich DH, et al. Mechanical coupling between myofibroblasts and cardiomyocytes slows electric conduction in fibrotic cell monolayers. Circulation 2011; 123: 2083-93.
64. Faggian L, Pampinella F, Roelofs M, et al. Phenotypic changes in the regenerating rabbit bladder muscle. Role of interstitial cells and innervation on smooth muscle cell differentiation. Histochem Cell Biol 1998; 109: 25-39.
65. Sui GP, Rothery S, Dupont E, et al. Gap junctions and connexin expression in human suburothelial interstitial cells. BJU Int 2002; 90: 118-29.
66. Wu C, Sui GP, Fry CH,. Purinergic regulation of guinea pig suburothelial myofibroblasts. J Physiol 2004; 559: 231-43.
67. Kanai A, Roppolo J, Ikeda Y, et al. Origin of spontaneous activity in neonatal and adult rat bladders and its enhancement by stretch and muscarinic agonists. Am J Physiol 2007; 292: F1065-72.
68. McMurray G, Dass N, Brading AF,. Purinoceptor subtypes mediating contraction and relaxation of marmoset urinary bladder smooth muscle. Br J Pharmacol 1998; 123: 1579-86.
69. Ikeda Y, Fry CH, Hayashi F, et al. Role of gap junctions in spontaneous activity of the rat bladder. Am J Physiol 2007; 293: F1018-25.
70. Kumar V, Chapple CR, Rosario D, et al. In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic. Eur Urol 2010; 57: 1087-92.
71. Harvey RA, Skennerton DE, Newgreen D, et al. The contractile potency of adenosine triphosphate and ecto-adenosine triphosphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder. J Urol 2002; 168: 1235-9.
72. Kosan M, Hafez G, Ozturk B, et al. Effect of urothelium on bladder contractility in diabetic rats. Int J Urol 2005; 12: 677-82.
73. Santoso AG, Sonarno IA, Arsad NA, et al. The role of the urothelium and ATP in mediating detrusor smooth muscle contractility. Urology 2010; 76: 1267.
74. Munoz A, Smith CP, Boone TB, et al. Removal of urothelium affects bladder contractility and release of ATP but not release of NO in rat urinary bladder. BMC Urol 2010; 10: 10.
75. Saban R, Keith I, Nielsen KT, et al. In vitro effects of bladder mucosa and an enkephalinase inhibitor on tachykinin induced contractility of the dog bladder. J Urol 1992; 147: 750-5.
76. Hawthorn MH, Chapple C, Cock M, et al. Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol 2000; 129: 416-9.
77. Chaiyaprasithi B, Mang C, Kilbinger H, et al. Inhibition of human detrusor contraction by a urothelium derived factor. J Urol 2003; 170: 1897-900.
78. Braverman AS, Lebed B, Linder M, et al. M2 mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors. Neurourol Urodyn 2007; 26: 63-70.
79. Birder LA,. More than just a barrier: Urothelium as a drug target for urinary bladder pain. Am J Physiol 2005; 289: F489-95.
80. Wu WR, Kong W, Pellicer A, et al. Uroplakins in urothelial biology, function and disease. Kidney Int 2009; 75: 1153-65.
81. Weng TI, Chen W, Wu HY, et al. Uropathogenic Escherichia coli alters muscle contractions in rat urinary bladder via a nitric oxide synthase-related signaling pathway. J Infect Dis 2006; 194: 1774-82.
82. Floyd RV, Winstanley C, Bakran A, et al. Modulation of ureteric Ca signaling and contractility in humans and rats by uropathogenic E. coli. Am J Physiol 2010; 298: F900-8.
83. Chowdhury P, Sacks S, Sheerin NS,. Minireview: Functions of the renal tract epithelium in coordinating the innate immune response to infection. Kidney Int 2004; 66: 1334-44.
84. Noda S, Eto K,. Histopathological studies on the cystic formation of the human urothelium. Kurume Med J 1990; 37: 55-65.
85. Shie JH, Kuo H,. Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome. BJU Int 2011; 108: E136-41.
86. Akkad T, Pelzer A, Mitterberger, et al. Influence of intravesical potassium on pelvic floor activity in women with overactive bladder syndrome: Comparative urodynamics might provide better detection of dysfunctional voiding. BJU Int 2007; 100: 830-4.
87. Kim JC, Yoo JS, Park EY, et al. Muscarinic and purinergic receptor expression in the urothelium of rats with detrusor overactivity induced by bladder outlet obstruction. BJU Int 2007; 101: 371-5.
88. Datta SN, Roosen A, Pullen A, et al. Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration. J Urol 2010; 184: 2578-85.
89. Janssen DA, Hoenderop J, Jansen KC, et al. The mechanoreceptor TRPV4 is localized in adherence junctions of the human bladder urothelium: A morphological study. J Urol 2011; 186: 1121-7.
90. Grol S, van Koeveringe GA, de Vente J, et al. Regional differences in sensory innervation and suburothelial interstitial cells in the bladder neck and urethra. BJU Int 2008; 102: 870-7.
91. van Koeveringe GA, Vahabi B, Andersson KE, et al. Detrusor underactivity: A plea for new approaches to a common bladder dysfunction. Neurourol Urodyn 2011; 30: 723-8.
92. Rofeim O, Hom D, Freid RM, et al. Use of the neodymium:YAG laser for interstitial cystitis: A prospective study. J Urol 2001; 166: 134-6.
93. Wefer B, Reitz A, Knapp PA, et al. Conditional stimulus can influence urethral sphincter contraction evoked by a magnetic stimulation. Neurourol Urodyn 2005; 24: 311-7.
94. Klarskov N, Lose G,. Urethral pressure reflectometry vs urethral pressure profilometry in women: A comparative study of reproducibility and accuracy. BJU Int 2007; 100: 351-6.
95. Klarskov N, Lose G,. Urethral pressure reflectometry and pressure profilometry in healthy volunteers and stress urinary incontinent women. Neurourol Urodyn 2008; 27: 807-12.
96. Klarskov N, Scholfield D, Soma K, et al. Measurement of urethral closure function in women with stress urinary incontinence. J Urology 2009; 181: 2628-33.
97. Munoz A, Smith C, Boone TB, et al. Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release. Neurochem Int 2011; 58: 295-300.
98. Mirone V, d'Emmanuele di Villa Bianca R, Mitidieri E, et al. Platelet cyclic guanosine monophosphate as a biomarker of phosphodiesterase type 5 inhibitor efficacy in the treatment of erectile dysfunction. Eur Urol 2009; 56: 1067-73.
99. Muntener M, Schurch B, Wefer B, et al. Systemic nitric oxide augmentation leads to a rapid decrease of the bladder outlet resistance in healthy men. Eur Urol 2006; 50: 112-8.
100. Templeman L, Sellers D, Chapple CR, et al. Investigation of neurokinin-2 and -3 receptors in the human and pig bladder. BJU Int 2003; 92: 787-92.
101. Bushfield M, Metcalfe M, Naylor AM,. Activation of the micturition reflex by NK2 receptor stimulation in the anaesthetized guinea-pig. Br J Pharmacol 1995; 115: 875-82.
102. Yamauchi H, Akino H, Ito H, et al. Urinary prostaglandin E2 was increased in patients with suprapontine brain diseases and associated with overactive bladder syndrome. Urology 2010; 76: 1267.e13-9.
103. Maggi CA,. Therapeutic potential of capsaicin-like molecules: Studies in animals and humans. Life Sci 1992; 51: 1777-81.
104. Chancellor MB, de Groat WC,. Intravesical capsaicin and resiniferatoxin therapy: Spicing up the ways to treat the overactive bladder. J Urol 1999; 162: 3-11.
105. Giannontoni A, Di Stasi SM, Chancellor MB, et al. New frontiers in intravesical therapies and drug delivery. Eur Urol 2006; 50: 1183-93.
106. GuhaSarkar S, Banerjee R,. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies. J Control Release 2010; 148: 147-59.
107. Mazzucchelli R, Barbisan F, Tarquini LM, et al. Urothelial changes induced by therapeutic procedures for bladder cancer. A review. Anal Quant Cytol Histol 2005; 27: 27-34.
108. Lewis SA,. Everything you wanted to know about the bladder epithelium but were afraid to ask. Am J Physiol 2000; 278: F867-74.
109. Di Stasi SM, Giannantoni A, Massoud R, et al. Electromotive administration of oxybutynin into the human bladder wall. J Urol 1997; 158: 228-33.
110. Di Stasi SM, Vespasiani G, Giannantoni A, et al. Electromotive delivery of mitomycin C into human bladder wall. Cancer Res 1997; 57: 875-80.